(0.26%) 5 145.00 points
(0.13%) 38 490 points
(0.41%) 17 920 points
(-0.79%) $83.19
(1.51%) $1.952
(-0.25%) $2 341.30
(-0.15%) $27.50
(2.69%) $946.95
(-0.12%) $0.934
(-0.14%) $11.01
(-0.34%) $0.798
(1.35%) $93.12
Live Chart Being Loaded With Signals
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A., a biotechnology company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland...
Stats | |
---|---|
今日成交量 | 300 036 |
平均成交量 | 209 727 |
市值 | 407.51M |
EPS | PLN0.0106 ( 2023-05-26 ) |
Last Dividend | PLN0 ( N/A ) |
Next Dividend | PLN0 ( N/A ) |
P/E | 52.73 |
ATR14 | PLN0.192 (3.58%) |
音量 相关性
BIOMED-LUBLIN Wytwórnia 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
BIOMED-LUBLIN Wytwórnia 相关性 - 货币/商品
BIOMED-LUBLIN Wytwórnia 财务报表
Annual | 2022 |
营收: | PLN50.38M |
毛利润: | PLN27.93M (55.44 %) |
EPS: | PLN0.0900 |
FY | 2022 |
营收: | PLN50.38M |
毛利润: | PLN27.93M (55.44 %) |
EPS: | PLN0.0900 |
FY | 2021 |
营收: | PLN41.15M |
毛利润: | PLN22.67M (55.08 %) |
EPS: | PLN0.0700 |
FY | 2020 |
营收: | PLN40.16M |
毛利润: | PLN20.57M (51.21 %) |
EPS: | PLN0.0700 |
Financial Reports:
No articles found.
BIOMED-LUBLIN Wytwórnia
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A., a biotechnology company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50, a product used in treating superficial (non-muscle invasive) bladder tumour; GAMMA anty HBs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunoglobulin products used in prevention of hemolytic disease of the foetus and newborn; BioTrombina 400, a medication for topical control of severe bleeding; and Anti-Tuberculosis Vaccine BCG 10, a medication used in tuberculosis prevention. It also offers medical products comprising Ram blood for laboratory use; stonebrink medium for biovine Mycobacterium tuberculosis diagnostics; Löwenstein-Jensen medium with medicines for testing medicine susceptibility of Mycobacterium tuberculosis; Löwenstein-Jensen medium containing glycerol is used for identification of Mycobacterium tuberculosis; Ox Thrombin for in-vitro diagnostics and Lyophilisate; and rabbit plasma. In addition, the company provides reagents, such as horse serum, bovine serum, calf serum, trypsin, PBS fluid, hanks fluid, parker's fluid, Eagle 1959 medium, RPMI 1640 medium, and Ogawa medium, as well as pseudo cholinesterase, Ox fibrinogen, and rabbit complements. The company was founded in 1944 and is based in Lublin, Poland.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。